Collaborative Grants Program

The Jacki and Bruce Barron Cancer Research Scholars’ Program will offer up to three one-year grants annually to support innovative basic, translational and clinical research into any type of cancer by scientists at City of Hope and collaborators in Israel. The intent of these grants is to fund promising new ideas and obtain the preliminary data needed to secure additional support from government and private sectors, including prevention, therapeutic development and early phase clinical trials.

City of Hope and Israel Cancer Research Fund will provide $150,000 for each partnership to be divided evenly between both institutions. Scientists in Israel will initiate interactions with City of Hope scientists by reviewing our areas of research and shared resources and submitting proposals to the program in accordance with the posted guidelines.

Funded Collaborations

RNA Editing Study May Unlock Secrets to How Natural Selection Aids Cancer Growth

Erez Y. Levanon, Ph.D.
Life Sciences, Bar-Ilan University

Researchers Looking to Identify Mechanisms That Cause Immune System to Help Cancer Growth

Zuoming Sun, Ph.D.
Immunology & Theranostics
City of Hope

Noah Isakov, Ph.D.
Ben-Gurion University

Immunology Experts Hope to Reveal Relationship Between Eosinophils and STAT3 in Cancer Metastasis

Hua Yu, Ph.D.
Cancer Immunotherapeutics                   
City of Hope

Ariel Munitz, Ph.D.
Microbiology and Clinical Immunology
Tel Aviv University
 

With New Study, Researchers Strive to Lower Risk of ALL Recurrence Among Children

Markus Müschen, M.D., Ph.D.
The Norman and Sadie Lee Foundation Endowed Professor in Pediatrics
Professor and Chair, Department of Systems Biology

Shai Izraeli, M.D.
Director, Department of Hematology-Oncology,
Schneider Children's Medical Center of Israel

Scientists Exploring How Specific Bacteria Hamper Cancer Treatments in New Study

Dan Raz, M.D.
Co-director, Lung Cancer and Thoracic Oncology Program
Assistant Professor, Division of Thoracic Surgery

Ravid Straussman, M.D., Ph.D.
The Roel C. Buck Career Development Chair,
Department of Molecular Cell Biology
Weizmann Institute of Science

Study Aims to Uncover Role of Tumor-Suppressing WWox Gene in Triple-Negative Breast Cancer

Victoria Seewaldt, M.D.
Ruth Ziegler Professor
Chair, Department of Population Sciences

Rami Aqeilan, Ph.D.
Professor, Lautenberg Center for Immunology and Cancer Research Hebrew University/Hadassah Medical School

Scientists Embark on Study to Develop More Inclusive, Cost-Effective Breast Cancer Screening

Jeffrey Weitzel, M.D.
Dr. Norman & Melinda Payson Professor in Medical Oncology
Director, Division of Clinical Cancer Genomics, Department of Population Sciences

Gad Rennert, M.D., Ph.D.
Director, Clalit National Israeli Cancer Control Center
Professor and Chairman, Department of Community Medicine and Epidemiology, Carmel Medical Center

Macrophages-Shuttling of miRNA Via Exosomes Reprograms Glucose Metabolism in Pancreatic

Mei Kong, Ph.D.
Cancer Biology
City of Hope

Ziv Gil, M.D., Ph.D.
Rambam Health Care Campus
Laboratory for Applied Cancer Research

Modifying the Prey: Targeting of Signal Regulators with siRNA for Improved Viral Oncolysis

Marcin Kortylewski, Ph.D.
Immuno-Oncology
City of Hope

Marcelo Ehrlich, Ph.D.
Tel Aviv University
Cell Research and Immunology

Metallocorroles for Imaging and Therapy in Malignant Melanoma

John Termini, Ph.D.
Molecular Medicine
City of Hope

Zeev Gross, Ph.D.
Technion, Israel Institute of Technology
Schulich Faculty of Chemistry
 

Sabbatical: Theranostic Metallodrugs for Imaging and Fighting Cancer

John Termini, Ph.D.
Molecular Medicine
City of Hope

Zeev Gross, Ph.D.
Technion, Israel Institute of Technology
Schulich Faculty of Chemistry

Developing Novel Therapeutic Approaches for High-Risk Acute Lymphoblastic Leukemia

Hua E. Yu, Ph.D.
Immuno-Oncology
City of Hope

Shai Izraeli, M.D.
Cancer Research Center
Chaim Sheba Medical Center               
               
Characterization Of the Lung Cancer Microbiome and Its Effects on Response lo Treatment
               
Dan Raz, M.D.
Surgery
City of Hope

Ravid Straussman, M.D., Ph.D.
Molecular Cell Biology
Weizmann Institute of Science     
                     
Spectrum Of Germline P53 and Somatic Genomic Variants in Israeli Breast Cancer Patients
               
Jeffrey Weitzel, M.D.
Population Sciences/Clinical Cancer Genetics
City of Hope

Gad Rennert, M.D., Ph.D.
Carmel Medical Center, Community Medicine and Epidemiology
Clalit National Cancer Control Center

WWOX Loss Activates Aerobic Glycolysis in TNBC
               
Victoria Seewaldt, M.D.
Population Sciences|
City of Hope

Rami Aqeilan, Ph.D.
Lautenberg Center for Immunology and Cancer Research
Hebrew University/Hadassah Medical School
               
Sabbatical: Distribution And Diffusion of Nanoparticles in Tumoral Tissue

Jacob Berlin, Ph.D.
Molecular Medicine
City of Hope

Abraham Domb, Ph.D.
School of Pharmacy
Hebrew University

Collaborative Areas of Research

The Jacki and Bruce Barron Cancer Research Scholars’ Program will foster collaborations across a wide scope of basic, translational and clinical research areas. Proposed projects must be focused on cancer. Program participants will have access to City of Hope's comprehensive range of scientific resources and interaction with faculty in numerous fields, including:

About the Israel Cancer Research Fund

Israel Cancer Research Fund, a 501(c)(3) organization, is the largest nationwide charitable organization in North America solely devoted to supporting cancer research in Israel. Since its establishment in 1975, ICRF has provided more than 2,200 grants to outstanding cancer researchers whose laboratories are located in all of the leading research institutions, universities and hospitals across Israel. For more information, visit www.icrfonline.org.